Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Young

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Investigational New Drugs|June 13, 2014
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabineLawrence M Gelbert, Shufen Cai, Xi Lin, et al.
BMJ Open|June 22, 2026
Oral oxycodone versus sublingual buprenorphine for postoperative pain control after pelvic exenteration (PROSPER): a pilot, registry-embedded, multi-centre, double-blind, placebo-controlled, randomised controlled trialCharlotte Johnstone, Cherry Koh, Stephanie Mathieson, et al.
Nature Genetics|April 10, 2025
A redefined InDel taxonomy provides insights into mutational signaturesGene Ching Chiek Koh, Arjun Scott Nanda, Giuseppe Rinaldi, et al.
Molecular Cancer Therapeutics|January 28, 2022
Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 AgonistsVera Grinkevitch, Mark Wappett, Nyree Crawford, et al.
Genome Research|February 10, 2017
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutationsJonathan S Brammeld, Mia Petljak, Inigo Martincorena, et al.
Nature Cancer|June 24, 2021
A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damageXueqing Zou, Gene Ching Chiek Koh, Arjun Scott Nanda, et al.
Science (New York, N.Y.)|August 11, 2022
Substitution mutational signatures in whole-genome-sequenced cancers in the UK populationAndrea Degasperi, Xueqing Zou, Tauanne Dias Amarante, et al.
Communications Biology|April 24, 2024
Genome-wide CRISPR screens identify the YAP/TEAD axis as a driver of persister cells in EGFR mutant lung cancerMatthias Pfeifer, Jonathan S Brammeld, Stacey Price, et al.
Elife|May 12, 2020
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmissionLucy Rivett, Sushmita Sridhar, Dominic Sparkes, et al.
Cell Reports|May 28, 2024
Insights from multi-omic modeling of neurodegeneration in xeroderma pigmentosum using an induced pluripotent stem cell systemCherif Badja, Sophie Momen, Gene Ching Chiek Koh, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|June 13, 2014
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabineLawrence M Gelbert, Shufen Cai, Xi Lin, et al.
BMJ Open|June 22, 2026
Oral oxycodone versus sublingual buprenorphine for postoperative pain control after pelvic exenteration (PROSPER): a pilot, registry-embedded, multi-centre, double-blind, placebo-controlled, randomised controlled trialCharlotte Johnstone, Cherry Koh, Stephanie Mathieson, et al.
Nature Genetics|April 10, 2025
A redefined InDel taxonomy provides insights into mutational signaturesGene Ching Chiek Koh, Arjun Scott Nanda, Giuseppe Rinaldi, et al.
Molecular Cancer Therapeutics|January 28, 2022
Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 AgonistsVera Grinkevitch, Mark Wappett, Nyree Crawford, et al.
Genome Research|February 10, 2017
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutationsJonathan S Brammeld, Mia Petljak, Inigo Martincorena, et al.
Nature Cancer|June 24, 2021
A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damageXueqing Zou, Gene Ching Chiek Koh, Arjun Scott Nanda, et al.
Science (New York, N.Y.)|August 11, 2022
Substitution mutational signatures in whole-genome-sequenced cancers in the UK populationAndrea Degasperi, Xueqing Zou, Tauanne Dias Amarante, et al.
Communications Biology|April 24, 2024
Genome-wide CRISPR screens identify the YAP/TEAD axis as a driver of persister cells in EGFR mutant lung cancerMatthias Pfeifer, Jonathan S Brammeld, Stacey Price, et al.
Elife|May 12, 2020
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmissionLucy Rivett, Sushmita Sridhar, Dominic Sparkes, et al.
Cell Reports|May 28, 2024
Insights from multi-omic modeling of neurodegeneration in xeroderma pigmentosum using an induced pluripotent stem cell systemCherif Badja, Sophie Momen, Gene Ching Chiek Koh, et al.
Pageof 5